Literature DB >> 17723325

Formation of osteoclast-like cells on HA and TCP ceramics.

R Detsch1, H Mayr, G Ziegler.   

Abstract

An essential property of bone substitute materials is that they are integrated into the natural bone remodelling process, which involves the resorption by osteoclast cells and the formation by osteoblast cells. If monocyte cells adhere to a calcium phosphate surface (bone or bone substitute material), they can fuse together and form multinucleated osteoclast cells. In this study we show that osteoclast-like cells derived from a human leukoma monocytic lineage responded in a different way to tricalciumphosphate (TCP) than to hydroxyapatite (HA) ceramics. Both ceramics were degraded by resorbing cells; however, HA enhanced the formation of giant cells. The osteoclast-like cells on HA formed a more pronounced actin ring, and larger lacunas could be observed. TCP ceramics are medically used as bone substitute materials because of their high dissolution rate. On the other hand, highly soluble calcium phosphate ceramics like TCP seem to be inappropriate for osteoclast resorption because they produce a high calcium concentration in the osteoclast interface and in the environment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723325     DOI: 10.1016/j.actbio.2007.03.014

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  28 in total

1.  Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits.

Authors:  En Luo; Jing Hu; Chongyun Bao; Yunfeng Li; Qisheng Tu; Dana Murray; Jake Chen
Journal:  Acta Biomater       Date:  2011-10-25       Impact factor: 8.947

2.  Comparison of three dissolution apparatuses for testing calcium phosphate pellets used as ibuprofen delivery systems.

Authors:  Emilie Chevalier; Marylène Viana; Aymeric Artaud; Lisette Chomette; Samir Haddouchi; Gille Devidts; Dominique Chulia
Journal:  AAPS PharmSciTech       Date:  2009-05-14       Impact factor: 3.246

3.  Effect of PEG amount in amorphous calcium phosphate on its crystallized products.

Authors:  Siqian Liu; Wenjian Weng; Zhongli Li; Lili Pan; Kui Cheng; Chenlu Song; Piyi Du; Ge Shen; Gaorong Han
Journal:  J Mater Sci Mater Med       Date:  2008-09-21       Impact factor: 3.896

4.  Osteoblast attachment to hydroxyapatite micro-tube scaffolds.

Authors:  E C Kolos; A J Ruys
Journal:  J Mater Sci Mater Med       Date:  2014-04-12       Impact factor: 3.896

5.  Bone augmentation in rabbit tibia using microfixed cobalt-chromium membranes with whole blood, tricalcium phosphate and bone marrow cells.

Authors:  Oscar Decco; Andrea Cura; Víctor Beltrán; María Lezcano; Wilfried Engelke
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Nanocrystalline spherical hydroxyapatite granules for bone repair: in vitro evaluation with osteoblast-like cells and osteoclasts.

Authors:  A Bernhardt; R Dittrich; A Lode; F Despang; M Gelinsky
Journal:  J Mater Sci Mater Med       Date:  2013-04-28       Impact factor: 3.896

7.  Static and dynamic cultivation of bone marrow stromal cells on biphasic calcium phosphate scaffolds derived from an indirect rapid prototyping technique.

Authors:  M Schumacher; F Uhl; R Detsch; U Deisinger; G Ziegler
Journal:  J Mater Sci Mater Med       Date:  2010-09-21       Impact factor: 3.896

8.  Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis.

Authors:  Siddharth P Pathi; Debra D W Lin; Jason R Dorvee; Lara A Estroff; Claudia Fischbach
Journal:  Biomaterials       Date:  2011-04-20       Impact factor: 12.479

9.  Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping.

Authors:  Mangal Roy; Susmita Bose
Journal:  J Biomed Mater Res A       Date:  2012-05-05       Impact factor: 4.396

10.  Effects of Zinc and Strontium Substitution in Tricalcium Phosphate on Osteoclast Differentiation and Resorption.

Authors:  Mangal Roy; Gary Fielding; Amit Bandyopadhyay; Susmita Bose
Journal:  Biomater Sci       Date:  2013-01       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.